Evommune EVMN
NYSE EVMN
$12.43 +0.43 (+3.54%)
As of: Sep 4, 2026 · 1:38 PM EDT

Evommune (EVMN) Property, Plant & Equipment (Net) (2024 - 2026)

Analysis

Evommune (EVMN) Property, Plant & Equipment (Net) (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 139.31 Bn 131.46 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.65 Bn 77.66 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 63.46 Bn 58.27 Bn 1.37 Bn 1.96 Bn
4 Moderna 57.94 Bn 52.80 Bn 52.00 Mn 2.06 Bn
5 Revolution Medicines 44.05 Bn 44.05 Bn - 34.61 Mn
6 BeOne Medicines 39.96 Bn 34.86 Bn 1.53 Bn 1.64 Bn
7 Alnylam Pharmaceuticals 35.16 Bn 31.85 Bn 992.69 Mn 554.14 Mn
8 Royalty Pharma 28.44 Bn 27.60 Bn - -
9 Insmed 27.32 Bn 26.16 Bn 358.27 Mn 107.22 Mn
10 Evommune 449.17 Mn 248.37 Mn - 1.65 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.65 Mn
Mar 31, 2026 1.64 Mn
Dec 31, 2025 994,000.00
Sep 30, 2025 970,000.00
Dec 31, 2024 1.33 Mn